MENU

HALO Halozyme Therapeutics Forecast, Technical & Fundamental Analysis

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HALO is expected to report earnings to fall 7.87% to $1.17 per share on February 25

Halozyme Therapeutics HALO Stock Earnings Reports
Q4'24
Est.
$1.17
Q3'24
Beat
by $0.31
Q2'24
Beat
by $0.15
Q1'24
Beat
by $0.10
Q4'23
Beat
by $0.02
The last earnings report on October 31 showed earnings per share of $1.27, beating the estimate of 95 cents. With 534.57K shares outstanding, the current market capitalization sits at 6.18B.
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
373
Web
https://www.halozyme.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

HALO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with VIR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+1.19%
VIR - HALO
38%
Loosely correlated
-2.78%
EYEN - HALO
36%
Loosely correlated
+7.84%
IDYA - HALO
36%
Loosely correlated
+1.07%
DNLI - HALO
36%
Loosely correlated
-0.30%
UTHR - HALO
36%
Loosely correlated
+1.84%
More